Viewing data from:

BUTORPHANOL TARTRATE

ANDA

BUTORPHANOL TARTRATE | A075697 | BAXTER HEALTHCARE CORP

1 strength0 unique patents0 unique exclusivities

Medicare Part B Spending

CMS physician-administered drug spending for Butorphanol Tartrate (2023)

Total Spending

$2K

Total Claims

356

Beneficiaries

152

ASP Price

—

HCPCS: J0595 — Injection, butorphanol tartrate, 1 mg

Source: CMS Medicare Part B Spending by Drug (2023). Shows physician-administered drug costs.

API Supply Chain4 active DMFs3 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

ABBVIE INCBUTORPHANOL TARTRATE

DMF 89041990

TAPI NL BVBUTORPHANOL TARTRATE

DMF 103851993

SRI KRISHNA PHARMACEUTICALS LTDBUTORPHANOL TARTRATE USP

DMF 256702012

HIKAL LTDBUTORPHANOL TARTRATE USP

DMF 318752017

NV ORGANONInactiveBUTORPHANOL TARTRATE

DMF 91271991

TASMANIAN ALKALOIDS PTY LTDInactiveBUTORPHANOL TARTRATE

DMF 121191996

ABBOTT LABORATORIES LTDInactiveBUTORPHANOL TARTRATE USP

DMF 129211998

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 2MG/ML

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Oct 23, 2001

No patent or exclusivity listings for this strength.